Scarica l'app Stockscreener
14.32
0.69%
-0.10
Dopo l'orario di chiusura:
14.32
Bausch Lomb Corp Borsa (BLCO) Ultime notizie
Analyzing drawdowns of Bausch + Lomb Corporation with statistical toolsMarket Movement Recap & Community Driven Trade Alerts - newser.com
Bausch + Lomb's (BLCO) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Global Myopia Treatment Devices Market Poised for Strong Growth at a CAGR of ~8% by 2032, Driven by Technological Innovations and Increasing Eye Care Demand | DelveInsight - GlobeNewswire Inc.
Bausch + Lomb Corp. Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators - Markets Mojo
Bausch + Lomb (NYSE:BLCO) Stock Price Expected to Rise, Evercore ISI Analyst Says - MarketBeat
What drives Bausch Lomb Corporation stock priceVolume Spike Alerts & Fast Growing Capital Growth - earlytimes.in
Bausch + Lomb Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
Can Bausch + Lomb Corporation (S2L) stock deliver strong annual returnsShare Buyback & Step-by-Step Trade Execution Guides - newser.com
Barclays Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Maintains Target Price $16 - 富途牛牛
Assessing Bausch + Lomb (NYSE:BLCO) Valuation as Goldman Sachs Brings New Spotlight to Ophthalmology Growth Prospects - simplywall.st
Bausch + Lomb (NYSE:BLCO) Coverage Initiated at The Goldman Sachs Group - MarketBeat
Is Bausch + Lomb Corporation (S2L) stock a momentum leaderMarket Risk Report & Consistent Income Trade Recommendations - newser.com
Applying Elliott Wave Theory to Bausch + Lomb CorporationQuarterly Market Review & Comprehensive Market Scan Reports - newser.com
Why Bausch + Lomb Corporation stock is upgraded to buy2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - newser.com
Goldman Sachs Initiates Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Announces Target Price $16 - 富途牛牛
Goldman Sachs initiates Bausch & Lomb stock with Neutral rating By Investing.com - Investing.com South Africa
Goldman Sachs initiates Bausch & Lomb stock with Neutral rating - Investing.com
BofA rates Bausch & Lomb ‘underperform’ with lower buyout chances - MSN
Is Zeal Aqua Limited a Smart Pick for Retirement PortfoliosEx-Dividend Date Alerts & Analyze Your Portfolio Risk in Seconds - earlytimes.in
Is Bausch + Lomb Corporation stock positioned for digital transformationMarket Growth Review & AI Driven Stock Reports - newser.com
Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13 - BioSpace
Global Eye Health Leader Bausch + Lomb Announces Q3 Earnings Date and Strategic Investor Day Pipeline Review - Stock Titan
Will Bausch + Lomb Corporation stock benefit from Fed rate cutsBuy Signal & Real-Time Volume Surge Alerts - newser.com
Why Bausch + Lomb Corporation stock could be next leaderJuly 2025 Catalysts & Verified Momentum Stock Ideas - newser.com
Bausch + Lomb, Enovis, and Haemonetics Shares Plummet, What You Need To Know - Yahoo Finance
Applying chart zones and confluence areas to Bausch + Lomb CorporationIndex Update & Safe Swing Trade Setup Alerts - newser.com
Bausch + Lomb: There Are Better Opportunities Out There (Rating Downgrade) - Seeking Alpha
Trade Recap: Why is Bausch Lomb Corporation stock going upJuly 2025 Market Mood & Safe Capital Growth Tips - خودرو بانک
Goldman Sachs Group Inc. Grows Position in Bausch + Lomb Corporation $BLCO - MarketBeat
Bausch + Lomb Corporation $BLCO Shares Sold by Dynamic Technology Lab Private Ltd - MarketBeat
Bausch + Lomb Corporation (NYSE:BLCO) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Vident Advisory LLC Makes New Investment in Bausch + Lomb Corporation $BLCO - MarketBeat
Aug Shorts: Is Bausch Lomb Corporation exposed to currency risksEarnings Recap Report & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Clearline Capital LP Acquires 247,149 Shares of Bausch + Lomb Corporation $BLCO - MarketBeat
Cubist Systematic Strategies LLC Takes $2.12 Million Position in Bausch + Lomb Corporation $BLCO - MarketBeat
Bausch + Lomb (NYSE:BLCO): Valuation Perspective After New Clinical Data and ASANA Lens Launch - Yahoo Finance
Revolutionary Full Range Vision Lens: Bausch + Lomb's enVista Envy Succeeds in 501-Patient Trial - Stock Titan
Bausch + Lomb (BLCO) Study Shows XIIDRA Eye Drops Improve Comfort For Contact Lens Wearers - Sahm
Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers - BioSpace
Bausch + Lomb (BLCO) Stock Trades Up, Here Is Why - Yahoo Finance
Little Excitement Around Bausch + Lomb Corporation's (NYSE:BLCO) Revenues - 富途牛牛
Bausch + Lomb Corporation - Baystreet.ca
Complete Custom Contact Lens Portfolio: Bausch + Lomb Launches ASANA for Complex Vision Conditions - Stock Titan
Is Bausch + Lomb Corporation being accumulated by smart money2025 Big Picture & Fast Momentum Entry Tips - خودرو بانک
Can trapped investors hope for a rebound in Bausch + Lomb CorporationTrade Entry Summary & Low Volatility Stock Suggestions - Newser
Is Bausch + Lomb Corporation exposed to currency risksJuly 2025 Movers & Low Risk High Win Rate Stock Picks - خودرو بانک
1.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):